Metformin Versus Vildagliptin for Diabetic Hypertensive Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT03253562
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- MTI University
- Registry
-
NCT03253562
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT03253562. Randomized; single masking; primary purpose treatment. Start 2017-02-01 (actual); primary completion 2017-08-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin Versus Vildagliptin for Diabetic Hypertensive Patients
- Condition
- Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients
- Intervention (Drug)
- Metformin Pill
- Intervention (Drug)
- Vildagliptin 50 mg
- Lead sponsor
- MTI University
Record details
- Record id
cardio:ct-nct03253562- Content hash
da92a8fcce77cbc9c92471fa123c85ef5dbd0a38f1c019c7d91314f511232b58